Skip to content

Author

Xueying Wei

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Epidemiological trends and risk factors of early-onset colorectal cancer in the founding BRICS countries, 1990–2023, with projections to 2050

Early-onset colorectal cancer (EOCRC) is increasing globally and represents an emerging public health concern. The BRICS countries (Brazil, Russia, India, China, and South Africa), accounting for ~40% of the global population, lack comprehensive epidemiological characterization. This study evaluates EOCRC burden, risk factors, trends (1990–2023), and projections to 2050. Using Global Burden of Disease 2023 (GBD 2023) data, we analyzed incidence, prevalence, mortality, and disability-adjusted life years (DALYs) of EOCRC among individuals aged 15–49 years in BRICS countries from 1990–2023, stratified by age, sex, and region. Behavioral, dietary, and metabolic risk factors were assessed for DALY attribution. Decomposition analysis identified drivers of change. SHAP quantified feature importance. A Bayesian Age–Period–Cohort (BAPC) model projected trends to 2050. External corroboration was performed in a retrospective cohort of 236 CRC patients from a tertiary hospital in China using logistic and Cox regression analyses. In 2023, China had the highest age-standardized incidence rate (ASIR) of EOCRC (3.83/100,000), while India had the lowest (1.26/100,000). From 1990–2023, Brazil showed the fastest ASIR increase (EAPC = 1.72), whereas China declined (EAPC =-1.19). Males consistently showed higher burden; in China, incidence in men aged 45–49 was 2.8-fold that of women. Key risk factors included low fiber intake, high red meat consumption, low milk intake, high BMI, and elevated fasting blood glucose, with strong co-occurrence. Decomposition analysis showed population growth and aging as main drivers, while epidemiological change varied, being positive in Brazil and negative for mortality in China. By 2050, India and South Africa are projected to show the largest increases, China will remain high with persistent sex disparities, and Russia will be stable or declining. In clinical corroboration, overweight/obesity was an independent risk factor (aOR = 2.14, 95% CI: 1.09–4.23), and diabetes predicted worse overall survival (HR = 4.35, 95% CI: 1.59–11.93), consistent with GBD-derived metabolic patterns. EOCRC burden varies across BRICS countries and will rise in most regions. Targeted prevention focusing on dietary and metabolic risks, plus early risk-stratified screening, is urgently needed, particularly in high-risk young males. The findings could help inform or guide future prevention and screening strategies.

Lin Zhang, Shu-Hua Zhuo, Xue-Ying Wei et al. · 0 citations
Open access Jul 2026

Temporal trends, risk factors, and future projections of gastric cancer burden in China, India, and the United States: a GBD 2023 analysis

The prevalence of gastric cancer (GC) in China, India, and the USA has different epidemiology, but comparative analyses with regard to their time trends and causes are underdeveloped. Using the 2023 Global Burden of Disease (GBD) database (1990–2023), we evaluated GC trends via Joinpoint regression. Das Gupta decomposition and comparative risk assessment quantified demographic/epidemiological drivers and behavioral risks. ARIMA models projected the burden through 2040. Globally, gastric cancer age-standardized incidence rates (ASIR) declined from 26.31 to 14.00 per 100,000 between 1990 and 2023, whereas absolute incident cases increased from 1.05 to 1.28 million. China maintained the highest disease burden in 2023 (ASIR: 25.04/100,000) despite achieving the steepest reductions in age-standardized incidence, mortality, and DALY rates. India demonstrated the slowest decline in age-standardized rates, while incident cases nearly doubled from 42,800 to 85,400 during the study period. Joinpoint analysis identified significant upward ASIR trends after 2020 in China (APC = 3.62) and globally (APC = 1.61). Smoking remained the leading attributable risk factor, particularly in China. Decomposition analysis showed that population aging and growth were the principal drivers of increasing absolute burden. ARIMA projections suggested that China will continue to carry the highest gastric cancer burden through 2040. Despite declining standardized rates, population aging and growth continue to drive absolute case numbers upward. To mitigate this evolving burden, China requires optimized early screening and stringent behavioral risk control; India needs expanded cancer registry coverage and equitable rural healthcare access; while the USA should prioritize targeted strategies to mitigate internal disparities among subpopulations.

Feng Lin, Xue-Ying Wei, Li-Huan Song et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.